Terms: = Endocrine gland cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Treatment
10 results:
1. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual treatment Report for 2013.
Nagase S; Ohta T; Takahashi F; Yamagami W; Yaegashi N;
J Obstet Gynaecol Res; 2022 Mar; 48(3):541-552. PubMed ID: 35026864
[TBL] [Abstract] [Full Text] [Related]
2. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract] [Full Text] [Related]
3. CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Codilupi T; Taube D; Naegeli H
BMC Cancer; 2019 Nov; 19(1):1042. PubMed ID: 31690264
[TBL] [Abstract] [Full Text] [Related]
4. Solid pseudopapillary tumor of the pancreas with liver metastasis: Clinical features and management.
Wang WB; Zhang TP; Sun MQ; Peng Z; Chen G; Zhao YP
Eur J Surg Oncol; 2014 Nov; 40(11):1572-7. PubMed ID: 24961631
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of ERCC1/xpf genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.
Deloia JA; Bhagwat NR; Darcy KM; Strange M; Tian C; Nuttall K; Krivak TC; Niedernhofer LJ
Gynecol Oncol; 2012 Sep; 126(3):448-54. PubMed ID: 22609620
[TBL] [Abstract] [Full Text] [Related]
6. Management of stage I testicular seminoma over a period of 49 years.
Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
[TBL] [Abstract] [Full Text] [Related]
7. The significance of duration of chemotherapy interruptions due to interval surgery in ovarian cancer patients treated with neoadjuvant chemotherapy.
Le T; Fathi KA; Hopkins L; Faught W; Fung-Kee-Fung M
J Obstet Gynaecol Can; 2009 Feb; 31(2):161-6. PubMed ID: 19327216
[TBL] [Abstract] [Full Text] [Related]
8. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.
Stevens EV; Nishizuka S; Antony S; Reimers M; Varma S; Young L; Munson PJ; Weinstein JN; Kohn EC; Pommier Y
Mol Cancer Ther; 2008 Jan; 7(1):10-8. PubMed ID: 18187810
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical research on 2228 cases of thyroid gland tumors].
Wang JD; Deng XC; Jin XJ; Zhou C; Zhang C; Xie M; Zhou JQ; Qian MF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr; 40(4):295-9. PubMed ID: 16008266
[TBL] [Abstract] [Full Text] [Related]
10. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours.
Köberle B; Masters JR; Hartley JA; Wood RD
Curr Biol; 1999 Mar; 9(5):273-6. PubMed ID: 10074455
[TBL] [Abstract] [Full Text] [Related]
